Share Email Print
cover

Proceedings Paper

Simulation of oblique-incidence probe geometries for depth-resolved fluorescence spectroscopy
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Optimization of device-tissue interface parameters may lead to an improvement in the efficacy of fluorescence spectroscopy for minimally-invasive disease detection. Although illumination-collection geometry has been shown to have a strong influence on the spatial origin of detected fluorescence, the performance of devices which deliver and/or collect light at oblique incidence are not well characterized or understood. Simulations were performed using a Monte Carlo model of light propagation in homogeneous tissue in order to identify and describe general trends in the intensity and spatial origin of fluorescence detected by angled geometries. Specifically, the influence of illumination angle, collection angle and illumination-collection spot separation distance were investigated for low and high attenuation tissue cases. Results indicated that oblique-incidence geometries have the potential to enhance the selective interrogation of superficial or subsurface fluorophores at user-selectable depths up to about 0.5 mm. Detected fluorescence intensity was shown to increase significantly with illumination and collection angle. Improved selectivity and signal intensity over normal-incidence geometries resulted from the overlap of illumination and collection cones within the tissue. Cases involving highly attenuating tissue produced a moderate reduction in the depth of signal origin. While Monte Carlo modeling indicates that oblique-incidence designs can facilitate depth-selective fluorescence spectroscopy, optimization of device performance will require application-specific consideration of optical and biological parameters.

Paper Details

Date Published: 7 October 2005
PDF: 8 pages
Proc. SPIE 5862, Diagnostic Optical Spectroscopy in Biomedicine III, 58620Q (7 October 2005); doi: 10.1117/12.633031
Show Author Affiliations
J. Pfefer, U.S. Food and Drug Administration (United States)
A. Agrawal, U.S. Food and Drug Administration (United States)
R. Drezek, Rice Univ. (United States)


Published in SPIE Proceedings Vol. 5862:
Diagnostic Optical Spectroscopy in Biomedicine III
Mary-Ann Mycek, Editor(s)

© SPIE. Terms of Use
Back to Top